The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
BAFF and MyD88 signals promote a lupuslike disease independent of T cells
Open accessAbstract
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by the production of autoantibodies. However, the underlying cause of disease appears to relate to defects in T cell tolerance or T cell help to B cells. Transgenic (Tg) mice overexpressing the cytokine B cell–activating factor of the tumor necrosis factor family (BAFF) develop an autoimmune disorder similar to SLE and show impaired B cell tolerance and altered T cell differentiation. We generated BAFF Tg mice that were completely deficient in T cells, and, surprisingly, these mice developed an SLE-like disease indistinguishable from that of BAFF Tg mice. Autoimmunity in BAFF Tg mice did, however, require B cell–intrinsic signals through the Toll-like receptor (TLR)–associated signaling adaptor MyD88, which controlled the production of proinflammatory autoantibody isotypes. TLR7/9 activation strongly up-regulated expression of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI), which is a receptor for BAFF involved in B cell responses to T cell–independent antigens. Moreover, BAFF enhanced TLR7/9 expression on B cells and TLR-mediated production of autoantibodies. Therefore, autoimmunity in BAFF Tg mice results from altered B cell tolerance, but requires TLR signaling and is independent of T cell help. It is possible that SLE patients with elevated levels of BAFF show a similar basis for disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL
Litinskiy, M. B., Nardelli, B., Hilbert, D. M., He, B., Schaffer, A., Casali, P., & Cerutti, A. (2002) · Nature Immunology · doi:10.1038/ni829 · Cited by 1,252
RetractedSchmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G., Moshrefi, M., Qin, J., Li, X., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.015 · Cited by 3,710
Targeted Disruption of the MyD88 Gene Results in Loss of IL-1- and IL-18-Mediated Function
Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K., & Akira, S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80596-8 · Cited by 2,041
Mice Transgenic for Baff Develop Lymphocytic Disorders along with Autoimmune Manifestations
Mackay, F., Woodcock, S. A., Lawton, P., Ambrose, C., Baetscher, M., Schneider, P., Tschopp, J., & Browning, J. L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.11.1697 · Cited by 1,480
Self-citationBAFF, a Novel Ligand of the Tumor Necrosis Factor Family, Stimulates B Cell Growth
Schneider, P., MacKay, F., Steiner, V., Hofmann, K., Bodmer, J.-L., Holler, N., Ambrose, C., Lawton, P., Bixler, S., Acha-Orbea, H., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.11.1747 · Cited by 1,333
Self-citationToll-like receptors in systemic autoimmune disease
Marshak-Rothstein, A. (2006) · Nature Reviews Immunology · doi:10.1038/nri1957 · Cited by 1,116
Christensen, S. R., Shupe, J., Nickerson, K., Kashgarian, M., Flavell, R. A., & Shlomchik, M. J. (2006) · Immunity · doi:10.1016/j.immuni.2006.07.013 · Cited by 1,090
BAFF and APRIL: A Tutorial on B Cell Survival
Mackay, F., Schneider, P., Rennert, P., & Browning, J. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141152 · Cited by 1,007
Self-citationType I Interferon in Systemic Lupus Erythematosus and Other Autoimmune Diseases
Banchereau, J., & Pascual, V. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.010 · Cited by 963
(2006) · Elsevier eBooks · doi:10.1016/b978-0-12-595961-2.x5000-8 · Cited by 962
Autoreactive B Cell Responses to RNA-Related Antigens Due to TLR7 Gene Duplication
Pisitkun, P., Deane, J. A., Difilippantonio, M. J., Tarasenko, T., Satterthwaite, A. B., & Bolland, S. (2006) · Science · doi:10.1126/science.1124978 · Cited by 894
Vinuesa, C. G., Cook, M. C., Angelucci, C., Athanasopoulos, V., Rui, L., Hill, K. M., Yu, D., Domaschenz, H., Whittle, B., Lambe, T., et al. (2005) · Nature · doi:10.1038/nature03555 · Cited by 862
Thien, M., Phan, T. G., Gardam, S., Amesbury, M., Basten, A., Mackay, F., & Brink, R. (2004) · Immunity · doi:10.1016/j.immuni.2004.05.010 · Cited by 746
Self-citationRecognition and Signaling by Toll-Like Receptors
West, A. P., Koblansky, A. A., & Ghosh, S. (2006) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.122303.115827 · Cited by 720
Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice
Mombaerts, P., Mizoguchi, E., Grusby, M. J., Glimcher, L. H., Bhan, A. K., & Tonegawa, S. (1993) · Cell · doi:10.1016/0092-8674(93)80069-q · Cited by 718
Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren’s syndrome
Groom, J., Kalled, S. L., Cutler, A. H., Olson, C., Woodcock, S. A., Schneider, P., Tschopp, J., Cachero, T. G., Batten, M., Wheway, J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214121 · Cited by 712
Self-citationBaff Mediates Survival of Peripheral Immature B Lymphocytes
Batten, M., Groom, J., Cachero, T. G., Qian, F., Schneider, P., Tschopp, J., Browning, J. L., & Mackay, F. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.10.1453 · Cited by 704
Self-citationFollicular B helper T cells in antibody responses and autoimmunity
Vinuesa, C. G., Tangye, S. G., Moser, B., & Mackay, C. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1714 · Cited by 624
Self-citationAdjuvant-Enhanced Antibody Responses in the Absence of Toll-Like Receptor Signaling
Gavin, A. L., Hoebe, K., Duong, B., Ota, T., Martin, C., Beutler, B., & Nemazee, D. (2006) · Science · doi:10.1126/science.1135299 · Cited by 581
Interleukin 1: An Immunological Perspective
Durum, S. (1985) · Annual Review of Immunology · doi:10.1146/annurev.immunol.3.1.263 · Cited by 580
TACI and BAFF-R mediate isotype switching in B cells
Castigli, E., Wilson, S. A., Scott, S., Dedeoglu, F., Xu, S., Lam, K.-P., Bram, R. J., Jabara, H., & Geha, R. S. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20032000 · Cited by 544
Regulation of the T-Independent Humoral Response by TACI
von Bülow, G.-U., van Deursen, J. M., & Bram, R. J. (2001) · Immunity · doi:10.1016/s1074-7613(01)00130-3 · Cited by 519
Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus
Christensen, S. R., Kashgarian, M., Alexopoulou, L., Flavell, R. A., Akira, S., & Shlomchik, M. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050338 · Cited by 516
Ng, L. G., Sutherland, A. P. R., Newton, R., Qian, F., Cachero, T. G., Scott, M. L., Thompson, J. S., Wheway, J., Chtanova, T., Groom, J., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.807 · Cited by 500
Self-citationT-bet regulates IgG class switching and pathogenic autoantibody production
Peng, S. L., Szabo, S. J., & Glimcher, L. H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082114899 · Cited by 497
Mills, J. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406303302608 · Cited by 407
Ehlers, M., Fukuyama, H., McGaha, T. L., Aderem, A., & Ravetch, J. V. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052438 · Cited by 339
He, B., Qiao, X., & Cerutti, A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.7.4479 · Cited by 296
Restoration of Tolerance in Lupus by Targeted Inhibitory Receptor Expression
McGaha, T. L., Sorrentino, B., & Ravetch, J. V. (2005) · Science · doi:10.1126/science.1105160 · Cited by 261
Toll-like Receptor 7-Dependent Loss of B Cell Tolerance in Pathogenic Autoantibody Knockin Mice
Berland, R., Fernandez, L., Kari, E., Han, J.-H., Lomakin, I., Akira, S., Wortis, H. H., Kearney, J. F., Ucci, A. A., & Imanishi-Kari, T. (2006) · Immunity · doi:10.1016/j.immuni.2006.07.014 · Cited by 256
Fukuyama, H., Nimmerjahn, F., & Ravetch, J. V. (2005) · Nature Immunology · doi:10.1038/ni1151 · Cited by 244
LENERT, P., BRUMMEL, R., Field, E. H., & ASHMAN, R. F. (2005) · Journal of Clinical Immunology · doi:10.1007/s10875-005-0355-6 · Cited by 234
Kalled, S. L., Cutler, A. H., Datta, S. K., & Thomas, D. W. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.5.2158 · Cited by 199
B-lymphocytes, innate immunity, and autoimmunity
Viau, M., & Zouali, M. (2005) · Clinical Immunology · doi:10.1016/j.clim.2004.08.019 · Cited by 183
Cutting Edge: BAFF Regulates CD21/35 and CD23 Expression Independent of Its B Cell Survival Function
Gorelik, L., Cutler, A. H., Thill, G., Miklasz, S. D., Shea, D. E., Ambrose, C., Bixler, S. A., Su, L., Scott, M. L., & Kalled, S. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.762 · Cited by 178
The BAFF/APRIL System: An Important Player in Systemic Rheumatic Diseases
Mackay, F., Sierro, F., Grey, S. T., & Gordon, T. P. (2004) · Current Directions in Autoimmunity · doi:10.1159/000082106 · Cited by 176
Self-citationA protective role for innate immunity in systemic lupus erythematosus
Carroll, M. C. (2004) · Nature Reviews Immunology · doi:10.1038/nri1456 · Cited by 175
Enzler, T., Bonizzi, G., Silverman, G. J., Otero, D. C., Widhopf, G. F., Anzelon-Mills, A. N., Rickert, R. C., & Karin, M. (2006) · Immunity · doi:10.1016/j.immuni.2006.07.010 · Cited by 173
B cell abnormalities in systemic lupus erythematosus.
Grammer, A. C., & Lipsky, P. E. (2003) · Arthritis Research · doi:10.1186/ar1009 · Cited by 170
Ettinger, R., Sims, G. P., Robbins, R., Withers, D., Fischer, R. T., Grammer, A. C., Kuchen, S., & Lipsky, P. E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.2872 · Cited by 167
BAFF Augments Certain Th1-Associated Inflammatory Responses
Sutherland, A. P. R., Ng, L. G., Fletcher, C. A., Shum, B. O. V., Newton, R. A., Grey, S. T., Rolph, M. S., Mackay, F., & Mackay, C. R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.9.5537 · Cited by 142
Self-citationActivation of Marginal Zone B Cells from Lupus Mice with Type A(D) CpG-Oligodeoxynucleotides
Brummel, R., & Lenert, P. S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.2429 · Cited by 142
Ostendorf, B., Iking-Konert, C., Kurz, K., et al. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.025858 · Cited by 130
The role of the BAFF/APRIL system in B cell homeostasis and lymphoid cancers
Mackay, F., & Tangye, S. G. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.02.009 · Cited by 123
Self-citationBao, L., Osawe, I., Haas, M., & Quigg, R. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.3.1947 · Cited by 115
Enhanced IgA Class Switching in Marginal Zone and B1 B Cells Relative to Follicular/B2 B Cells
Kaminski, D. A., & Stavnezer, J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.6025 · Cited by 90
Rituximab: A promising therapy in systemic lupus erythematosus
Thatayatikom, A., & White, A. J. (2005) · Autoimmunity Reviews · doi:10.1016/j.autrev.2005.05.006 · Cited by 89
BAFF costimulation of Toll‐like receptor‐activatedB‐1 cells
Ng, L. G., Ng, C., Woehl, B., Sutherland, A. P. R., Huo, J., Xu, S., Mackay, F., & Lam, K. (2006) · European Journal of Immunology · doi:10.1002/eji.200635956 · Cited by 82
Self-citationTh1 cytokines in the pathogenesis of lupus nephritis: The role of IL-18
Calvani, N., Tucci, M., Richards, H. B., Tartaglia, P., & Silvestris, F. (2005) · Autoimmunity Reviews · doi:10.1016/j.autrev.2005.04.009 · Cited by 81
CD40 ligation in B cell activation, isotype switching and memory development
Gray, D., Siepmann, K., & Wohlleben, G. (1994) · Seminars in Immunology · doi:10.1006/smim.1994.1039 · Cited by 81
The role of toll-like receptors in systemic lupus erythematosus
Rahman, A. H., & Eisenberg, R. A. (2006) · Springer Seminars in Immunopathology · doi:10.1007/s00281-006-0034-3 · Cited by 79
Is IgG2a a good Thl marker in mice?
Martin, R. M., & Lew, A. M. (1998) · Immunology Today · doi:10.1016/s0167-5699(97)87499-3 · Cited by 78
Fletcher, C. A., Sutherland, A. P. R., Groom, J. R., Batten, M., Ng, L. G., Gommerman, J. L., & Mackay, F. (2006) · European Journal of Immunology · doi:10.1002/eji.200636270 · Cited by 76
Self-citationThe role of BLyS/BLyS receptors in anti-chromatin B cell regulation
Hondowicz, B. D., Alexander, S. T., Quinn, W. J., Pagán, A. J., Metzgar, M. H., Cancro, M. P., & Erikson, J. (2007) · International Immunology · doi:10.1093/intimm/dxm011 · Cited by 73
Pathogenesis and treatment of systemic lupus erythematosus nephritis
Davidson, A., & Aranow, C. B. (2006) · Current Opinion in Internal Medicine · doi:10.1097/01.bor.0000240356.45550.13 · Cited by 64
Toll‐Like Receptor Activation in the Pathogenesis of Systemic Lupus Erythematosus
Means, T. K., & Luster, A. D. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1358.027 · Cited by 63
Role of anti-DNA antibodies in the pathogenesis of lupus nephritis
Deshmukh, U. S., Bagavant, H., & Fu, S. M. (2005) · Autoimmunity Reviews · doi:10.1016/j.autrev.2005.10.010 · Cited by 60
SLE: translating lessons from model systems to human disease
Singh, R. R. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.08.013 · Cited by 56
BAFF and LPS cooperate to induce B cells to become susceptible to CD95/Fas‐mediated cell death
Rodríguez, E. V. A., Craxton, A., Hendricks, D. W., Merino, M. C., Montes, C. L., Clark, E. A., & Gruppi, A. (2007) · European Journal of Immunology · doi:10.1002/eji.200636698 · Cited by 44
Muro, Y. (2005) · Autoimmunity · doi:10.1080/08916930400024612 · Cited by 43
Co‐Stimulatory Blockade in the Treatment of Murine Systemic Lupus Erythematosus (SLE)
Davidson, A., Wang, X., Mihara, M., Ramanujam, M., Huang, W., Schiffer, L. E., & Sinha, J. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb06048.x · Cited by 36
Spontaneous B cell hyperactivity in autoimmune-prone MRL mice
Nijnik, A., Ferry, H., Lewis, G., Rapsomaniki, E., Leung, J. C. H., Daser, A., Lambe, T., Goodnow, C. C., & Cornall, R. J. (2006) · International Immunology · doi:10.1093/intimm/dxl047 · Cited by 28
Discriminating Microbe from Self Suffers a Double Toll
Goodnow, C. C. (2006) · Science · doi:10.1126/science.1129797 · Cited by 25
Cell penetration by antiphospholipid autoantibodies
Cheng, H. (1998) · Immunology Today · doi:10.1016/s0167-5699(97)87498-1 · Cited by 17
Cited by
Mackay, F., & Schneider, P. (2009) · Nature Reviews Immunology · doi:10.1038/nri2572 · Cited by 930
Self-citationMarginal zone B cells: virtues of innate-like antibody-producing lymphocytes
Cerutti, A., Cols, M., & Puga, I. (2013) · Nature Reviews Immunology · doi:10.1038/nri3383 · Cited by 777
Systemic lupus erythematosus: Diagnosis and clinical management
Fava, A., & Petri, M. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.11.001 · Cited by 754
Pattern recognition receptors and control of adaptive immunity
Palm, N. W., & Medzhitov, R. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00731.x · Cited by 729
B cell depletion therapies in autoimmune disease: advances and mechanistic insights
Lee, D. S. W., Rojas, O. L., & Gommerman, J. L. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00092-2 · Cited by 658
Metadata
- Authors
- Groom, J. R., Fletcher, C. A., Walters, S. N., Grey, S. T., Watt, S. V., Sweet, M. J., Smyth, M. J., Mackay, C. R., & Mackay, F.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2007-07-30
- Volume
- 204
- Issue
- 8
- Pages
- 1959-1971
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2132773720
- Cited by
- 377
- References
- 64
- FWCI
- 17.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.